Guggenheim Initiates Coverage on Immunic with Buy Rating and $7 Price Target

martes, 24 de marzo de 2026, 7:47 am ET1 min de lectura
IMUX--

Guggenheim Initiates Coverage on Immunic with Buy Rating and $7 Price Target

Guggenheim Initiates Coverage on Immunic with Buy Rating and $7 Price Target

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios